![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 513/04 | (2006.01) |
A61K 31/433 | (2006.01) | ||
A61P 25/08 | (2006.01) |
(11) | Number of the document | 2491045 |
(13) | Kind of document | T |
(96) | European patent application number | 10781818.9 |
Date of filing the European patent application | 2010-10-21 | |
(97) | Date of publication of the European application | 2012-08-29 |
(45) | Date of publication and mention of the grant of the patent | 2015-12-23 |
(46) | Date of publication of the claims translation | 2016-04-11 |
(86) | Number | PCT/EP2010/006434 |
Date | 2010-10-21 |
(87) | Number | WO 2011/047860 |
Date | 2011-04-28 |
(30) | Number | Date | Country code |
09173912 | 2009-10-23 | EP |
(72) |
QUESNEL, Yannick, BE
TURET, Laurent, BE
MERCIER, Joėl, BE
|
(73) |
UCB Biopharma SPRL,
60, Allée de la Recherche, 1070 Brussels,
BE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 2-Okso-1-pirolidinil-imidazotiadiazolo dariniai |
2-OXO-1-PYRROLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES |
Payment date | Validity (years) | Amount | |
2023-10-02 | 14 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-10-21 |